Form 4: Colgate-Palmolive Director Steven A. Cahillane Reports Stock and Option Grants

Sentiment:

SEC Form 4 Filing


Director Steven A. Cahillane reports receiving stock and option grants from Colgate-Palmolive on May 13, 2024.

Summary

  • On May 13, 2024, Steven A. Cahillane, a director of Colgate-Palmolive, reported transactions involving the company's securities.
  • Cahillane acquired 1,905 shares of common stock at $0.00, representing an annual director stock grant.
  • He also acquired a stock option to purchase 2,201 shares of common stock at an exercise price of $94.46, also an annual director stock option grant.
  • Cahillane disposed of 4,719 shares of common stock.
  • The stock option becomes exercisable in equal annual installments over three years, starting on May 13, 2025, and expires on May 13, 2032.
  • Following these transactions, Cahillane directly owns 2,201 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing director compensation. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

  • The grants of stock and options to a director align their interests with those of shareholders.

Negatives

  • The disposal of 4,719 shares of common stock by the director could be interpreted negatively by some investors.

Risks

  • There are no specific risks mentioned in this document.

Industry Context

This is a standard regulatory filing related to director compensation, common in publicly traded companies.

Comparison to Industry Standards

  • Director compensation packages often include a mix of stock and option grants to incentivize performance and align with shareholder interests.
  • The vesting schedule of the options (three years) is a common practice.
  • Comparing the size of the grant to those of directors at peer companies like Procter & Gamble (PG) or Unilever (UL) would provide further context.

Stakeholder Impact

  • The stock and option grants could have a minor positive impact on shareholder value if the director's performance improves as a result of the incentive.

Key Dates

DateDescription
05/13/2024Date of stock and option grants and disposal of shares.
05/13/2025First anniversary of the option grant date; options become exercisable in installments.
05/13/2032Expiration date of the stock option.
05/15/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.